NORMOSOL-M AND DEXTROSE (dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate)

**Product type:** Human Prescription Drug

**Active ingredient:** DEXTROSE MONOHYDRATE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE

**Strength:** 5; 21; 128; 234 g/100mL; mg/100mL; mg/100mL; mg/100mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** ICU Medical Inc.

**Marketing category:** NDA (NDA017610)

**Pharmacologic class:** Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]